Paramasivan Sathish, Bassiouni Ahmed, Shiffer Arron, Dillon Matthew R, Cope Emily K, Cooksley Clare, Ramezanpour Mahnaz, Moraitis Sophia, Ali Mohammad Javed, Bleier Benjamin, Callejas Claudio, Cornet Marjolein E, Douglas Richard G, Dutra Daniel, Georgalas Christos, Harvey Richard J, Hwang Peter H, Luong Amber U, Schlosser Rodney J, Tantilipikorn Pongsakorn, Tewfik Marc A, Vreugde Sarah, Wormald Peter-John, Caporaso J Gregory, Psaltis Alkis J
Department of Otolaryngology, Head and Neck Surgery, University of Adelaide, Adelaide, SA, Australia.
Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.
Allergy. 2020 Aug;75(8):2037-2049. doi: 10.1111/all.14276. Epub 2020 Mar 30.
The sinonasal microbiome remains poorly defined, with our current knowledge based on a few cohort studies whose findings are inconsistent. Furthermore, the variability of the sinus microbiome across geographical divides remains unexplored. We characterize the sinonasal microbiome and its geographical variations in both health and disease using 16S rRNA gene sequencing of 410 individuals from across the world. Although the sinus microbial ecology is highly variable between individuals, we identify a core microbiome comprised of Corynebacterium, Staphylococcus, Streptococcus, Haemophilus and Moraxella species in both healthy and chronic rhinosinusitis (CRS) cohorts. Corynebacterium (mean relative abundance = 44.02%) and Staphylococcus (mean relative abundance = 27.34%) appear particularly dominant in the majority of patients sampled. Amongst patients suffering from CRS with nasal polyps, a statistically significant reduction in relative abundance of Corynebacterium (40.29% vs 50.43%; P = .02) was identified. Despite some measured differences in microbiome composition and diversity between some of the participating centres in our cohort, these differences would not alter the general pattern of core organisms described. Nevertheless, atypical or unusual organisms reported in short-read amplicon sequencing studies and that are not part of the core microbiome should be interpreted with caution. The delineation of the sinonasal microbiome and standardized methodology described within our study will enable further characterization and translational application of the sinus microbiota.
鼻窦微生物群仍未得到充分定义,我们目前的认知基于少数队列研究,但其结果并不一致。此外,鼻窦微生物群在不同地理区域的变异性仍未得到探索。我们使用对来自世界各地的410名个体进行16S rRNA基因测序的方法,对健康和患病状态下的鼻窦微生物群及其地理差异进行了表征。尽管个体之间的鼻窦微生物生态高度可变,但我们在健康和慢性鼻-鼻窦炎(CRS)队列中均识别出了一个由棒状杆菌属、葡萄球菌属、链球菌属、嗜血杆菌属和莫拉克斯氏菌属组成的核心微生物群。在大多数采样患者中,棒状杆菌属(平均相对丰度 = 44.02%)和葡萄球菌属(平均相对丰度 = 27.34%)显得尤为占优势。在患有鼻息肉的CRS患者中,发现棒状杆菌属的相对丰度有统计学意义的降低(40.29% 对50.43%;P = 0.02)。尽管我们队列中的一些参与中心在微生物群组成和多样性方面存在一些测量差异,但这些差异不会改变所描述的核心微生物的总体模式。然而,在短读长扩增子测序研究中报告的非核心微生物群组成部分的非典型或不寻常微生物应谨慎解读。我们研究中所描述的鼻窦微生物群的界定和标准化方法将有助于对鼻窦微生物群进行进一步表征和转化应用。